Szczegóły Szczegóły PDF BIBTEX RIS Tytuł artykułu Growth factor and cytokine interactions in myogenesis. Part II. Expression of IGF binding proteins and protein kinases essential for myogenesis in mouse C2C12 myogenic cells exposed to TNF-α and IFN-γ Tytuł czasopisma Polish Journal of Veterinary Sciences Rocznik 2011 Numer No 3 Autorzy Wieteska-Skrzeczyńska, W. ; Grzelkowska-Kowalczyk, K. ; Rejmak, E. Wydział PAN Nauki Biologiczne i Rolnicze Wydawca Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn Data 2011 Identyfikator DOI: 10.2478/v10181-011-0063-2 ; ISSN 1505-1773 Źródło Polish Journal of Veterinary Sciences; 2011; No 3 Referencje G Adams (2010), Insulin-like growth factor I signaling in skeletal muscle and the potential for cytokine interactions, Med Sci Sports Exerc, 42, 50, doi.org/10.1249/MSS.0b013e3181b07d12 ; S Adi (2002), Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation, Endocrinology, 143, 511, doi.org/10.1210/en.143.2.511 ; C De Alvaro (2008), Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kB are required for C2C12-RasV12C40 myoblast differentiation, Endocrinology, 149, 793, doi.org/10.1210/en.2007-0657 ; A de Thonel (2010), Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis, Mol Biol Cell, 21, 1423, doi.org/10.1091/mbc.E09-10-0847 ; C Duan (2010), Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation, Gen Comp Endocrinol, 167, 344, doi.org/10.1016/j.ygcen.2010.04.009 ; L Fernandez-Celemin (2002), Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α, Am J Physiol Endocrinol Metab, 283. ; S Firth (2002), Cellular actions of the insulin-like growth factor binding proteins, Endocr Rev, 23, 824, doi.org/10.1210/er.2001-0033 ; K Grzelkowska-Kowalczyk (2010), Treatment with TNF-α and IFN-γ alters the activation of SER/THR protein kinases and the metabolic response to IGF-I in mouse C2C12 myogenic cells, Cell Mol Biol Lett, 15, 13, doi.org/10.2478/s11658-009-0033-1 ; J Hirosumi (2002), A central role for JNK in obesity and insulin resistance, Nature, 420, 333, doi.org/10.1038/nature01137 ; M Igarashi (2007), Characterization of activation of MAP kinase superfamily in vasculature from diabetic rats, J Atheroscler Thromb, 14, 235, doi.org/10.5551/jat.E514 ; S Jacobi (2006), Adipocytes, myofibers, and cytokine biology: new horizons in the regulation of growth and body composition, J Animal Sci, 84. ; E Jennische (2000), Expression and localisation of IGF-binding protein mRNAs in regenerating rat skeletal muscle, APMIS, 108, 747, doi.org/10.1034/j.1600-0463.2000.d01-24.x ; C Jo (2009), MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation, Cell Signal, 21, 1910, doi.org/10.1016/j.cellsig.2009.08.008 ; C Lang (2002), Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection, Curr Opin Clin Nutr Metab Care, 5, 271, doi.org/10.1097/00075197-200205000-00006 ; F Mourkioti (2005), IGF-I, inflammation and stem cells: interactions during muscle regeneration, Trends Immunol, 26, 535, doi.org/10.1016/j.it.2005.08.002 ; Y Ning (2006), Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5, Mol Endocrinol, 20, 2173, doi.org/10.1210/me.2005-0196 ; G Nystrom (2009), Local insulin-like growth factor I prevents sepsis-induced muscle atrophy, Metabolism, 58, 787, doi.org/10.1016/j.metabol.2009.01.015 ; N Oksbjerg (2004), Basic principles of muscle development and growth in meat-producing mammals as affected by the insulin-like growth factor (IGF) system, Domest Anim Endocrinol, 27, 219, doi.org/10.1016/j.domaniend.2004.06.007 ; J Paye (2006), Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors, Ann Biomed Eng, 34, 618, doi.org/10.1007/s10439-005-9064-6 ; I Plaisance (2008), TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK, Am J Physiol Endocrinol Metab, 294. ; J Schertzer (2007), Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice, Am J Pathol, 171, 1180, doi.org/10.2353/ajpath.2007.070292 ; A Solomon (2006), Modifying muscle mass - the endocrine perspective, J Endocrinol, 191, 349, doi.org/10.1677/joe.1.06837 ; J-P Thissen (2007), How proinflammatory cytokines may impair growth and cause muscle wasting, Horm Res, 67, 64, doi.org/10.1159/000097555 ; N Tiffin (2004), Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation, Endocrinology, 145, 4991, doi.org/10.1210/en.2004-0101 ; G Tripathi (2009), IGF-independent effects of insulin-like growth factor binding protein-5 (igfbp5) in vivo, FASEB J, 23, 2616, doi.org/10.1096/fj.08-114124 ; T Vary (2004), Diminished ERK 1/2 and p38 MAPK phosphorylation in skeletal muscle during sepsis, Shock, 22, 548, doi.org/10.1097/01.shk.0000144131.13900.ff< ; P Yin (2004), Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis, J Biol Chem, 279, 32660, doi.org/10.1074/jbc.M401378200